Incepta Pharmaceuticals Ltd.
π§π©Bangladesh
- Country
- π§π©Bangladesh
- Ownership
- Private
- Established
- 1999-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.inceptapharma.com
A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)
Phase 1
Active, not recruiting
- Conditions
- Breast CancerBreast NeoplasmsBreast DiseaseAntineoplastic Agents
- Interventions
- Drug: Trastuzumab (proposed Trastuzumab biosimilar)Drug: Herclon
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Incepta Pharmaceuticals Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT06886659
- Locations
- π§π©
Al-Manar Hospital Ltd,, Dhaka, Bangladesh
π§π©Universal Medical College, Dhaka, Bangladesh
A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
Phase 3
Recruiting
- Conditions
- Diabetic Macular EdemaRetinal DiseaseMacular EdemaDiabetic RetinopathyMacular DegenerationRetinal Degeneration
- Interventions
- First Posted Date
- 2024-03-12
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Incepta Pharmaceuticals Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT06305416
- Locations
- π§π©
Bangladesh Eye Hospital & Institute, Dhaka, Bangladesh
Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2021-09-28
- Lead Sponsor
- Incepta Pharmaceuticals Ltd
- Target Recruit Count
- 480
- Registration Number
- NCT05056558
- Locations
- π§π©
Dhaka Medical College, Mugda Medical College, Kuwait Bangladesh Friendship Government Hospital, Dhaka, Bangladesh
Β© Copyright 2025. All Rights Reserved by MedPath